热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
产品名称：
PE/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
产品类别：
抗体
产品编号：
108415
产品应用：
108415
[价格]
规格 价格 库存
25µg ￥ 1232 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16,33-35, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note:?For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 108436).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  33. Whiteland J, et al. 1994 J Histochem Cytochem 43:3 (IHC-P)
  34. Brown C, et al. 2003 J Immunology 171:2 (IHC-P)
  35. Obregon-Henao A, et al. PLoS One 8:11 (IHC-P)
Product Citations
  1. Montagner S, et al. 2016. Cell Rep. 15: 1566-1579. PubMed
  2. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  3. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  4. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  5. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  6. Casellas Roman HL, et al. 2020. Leuk Res. 94:106372. PubMed
  7. Nagamachi A, et al. 2021. J Clin Invest. 131:. PubMed
  8. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  9. Bieren J, et al. 2015. J Immunol. 194:1154. PubMed
  10. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  11. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  12. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  13. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  14. Gritsina G, et al. 2015. Mol Cancer Ther. 14:1035. PubMed
  15. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  16. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  17. Stahlhut M, et al. 2021. Sci Rep. 11:5294. PubMed
  18. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  19. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  20. Jakob L, et al. 2021. Int J Mol Sci. 22:. PubMed
  21. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  22. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  23. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  24. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  25. Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
  26. Davis M, et al. 2015. J Immunol. 194:2219. PubMed
  27. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  28. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  29. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  30. Madsen P, et al. 2016. J Cereb Blood Flow Metab. 36: 1553 - 1569. PubMed
  31. Mehta C, et al. 2021. Nucleic Acids Res. 49:9007. PubMed
  32. Brusilovsky M, et al. 2021. Nat Immunol. 22:1316. PubMed
  33. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  34. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  35. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  36. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  37. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  38. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  39. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  40. Cencic R, et al. 2009. PLoS One. 4:e5223. PubMed
  41. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  42. Sch?nberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  43. Valkenburg S, et al. 2016. Sci Rep. 6:22666. PubMed
  44. Xie X, et al. 2015. Sci Rep. 5: 18115. PubMed
  45. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  46. Hoffmann O, et al. 2015. Infect Immun . 83:259. PubMed
  47. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  48. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  49. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  50. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  51. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  52. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  53. Hartwig T et al. 2017. Molecular cell. 65(4):730-742 . PubMed
  54. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  55. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  56. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  57. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  58. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  59. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  60. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  61. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  62. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  63. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID
AB_313380 (BioLegend Cat. No. 108415) AB_313381 (BioLegend Cat. No. 108416)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G Ly-6C on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线